fda glp-1 warning september 2025 news Drug Recalls and Warnings: Illegal Sales and Misleading Marketing by Novo Nordisk and Eli Lilly What Patients Need to Know

The increased demand for this diabetes drug extends not just among people with diabetes but also among the population seeking it for its weight-loss benefits, sometimes used off-label by nondiabetic individuals

While this property of DMSO may provide protection against high levels of ROS, at normal or decreased levels of ROS, it may hamper basal cell metabolism by scavenging electrons needed for ATP production 24

Clinical Evidence 2026 Update: Phase 3 TRIUMPH Data In December 2025, Eli Lilly reported the first successful Phase 3 readout for retatrutide (LY3437943) from the TRIUMPH-4 trial

Disulfide linkage Braatz et al

On a missed dose, the labels state that it should be administered as soon as possible within 4 days, and that if more than 4 days have passed the missed dose should be skipped and the next dose administered on the regularly scheduled day